Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$57.21 -0.25 (-0.44%)
2/9/2010 4:00 PM

Amgen, Inc. (AMGN)

CAPS Rating:
****

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating AMGN

Add Stock to Watchlist

What the Community Thinks

Total Members

1944 Outperforms
156 Underperforms
 

All-Stars

529 Outperforms
26 Underperforms
 

Wall Street

25 Outperforms
0 Underperforms
 

Members bullish on AMGN are also bullish on:

Members bearish on AMGN are also bearish on:

Ticker Tags

Biotechnology (220), Serial Acquirer (9), Business Week 50 (48), California (37), S&P 500 (499), Genomics (14), Thousand Oaks (1), Defensive (1457), Rule Breakers Universe (125), Growth (1902), Nasdaq 100 (85), Dermatology (4), Mega Cap (110), Healthcare (711)
Suggest a tag

Amgen, Inc. At A Glance

Current Price: $57.21
Last Trade Time: 2/9/2010 4:00 PM
Open: $58.24
Previous Close: $57.46
Daily Range: $56.70 - $58.40
52-Week Range: $44.96 - $64.76
Volume: 18,720,370
Market Cap: $57.90B
P/E Ratio: 11.63
Compare Our Special Broker Offers!

Stock Trends

AMGN VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Amgen, Inc. (AMGN)

Avatar zzlangerhans (99.64) Submitted: 2/27/09 1:12 AM

Just as Obama enthusiasm for stem cell stocks is senseless, Obama pessimism for pharmaceuticals is overblown. I don't believe his policies will fundamentally change the business model or profitability of mid-to-large cap biotechs, and I see this as another opportunity to green thumb some quality com...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

2

Amgen, Inc. (AMGN)

Avatar Jorgedig (44.24) Submitted: 12/01/07 12:25 PM

I sold my Amgen just before the new, strict Medicare guidelines came through on the use of Aranesp to treat chemotherapy-induced anemia.





I work in a cancer clinic, and we are very concerned that many of our patients are denied this important drug until their hematocrits are ...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 346 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (AMGN)

Avatar Monroe7 (42.82) Submitted: 2/07/10 9:46 PM : Outperform Start Price: $57.54 AMGN Score: -1.02

Should easily outperform by the end of this year. Right now it is trading at a very attractive price.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AMGN)

Avatar richardrogers4 (65.05) Submitted: 2/03/10 3:57 AM : Outperform Start Price: $58.90 AMGN Score: -0.45

Technical breakout

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AMGN)

Avatar iddqkfyou (< 20) Submitted: 1/29/10 5:19 AM : Outperform Start Price: $57.77 AMGN Score: 4.15

This is an insanely low P/E! They are in the business of, their profits go towards, new levels of life extension. Maybe you and I will not have much rejuvenatory medicine --- the unborn surely will --- but it will not be due to a lack of spending on it.

Start saving now though!! Your insurance does not cover "preventative" treatments.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AMGN)

Avatar punchjoel (< 20) Submitted: 1/27/10 10:44 PM : Outperform Start Price: $57.87 AMGN Score: 1.57

I like the steady earnings growth for the last 5 years

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AMGN)

Avatar Biotech2010 (40.47) Submitted: 1/26/10 8:52 PM : Outperform Start Price: $56.44 AMGN Score: 3.15

57.04

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 346 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 25 of 25  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackUBS 87.99 10/13/09 Outperform NS $60.03-4.70%-0.50%-4.20
TrackRBCCapMkts 86.33 08/11/09 Outperform NS $61.02-6.24%+7.17%-13.41
TrackRWBaird 87.00 04/24/09 Outperform NS $48.07+19.01%+26.00%-6.98
TrackJimCramer < 20 03/06/09 Outperform 3W $46.38+23.35%+58.33%-34.98
TrackLeerinkSwan 92.83 08/20/08 Outperform NS $64.05-10.68%-13.14%+2.47
TrackBofASec 94.61 08/04/08 Outperform NS $63.17-9.44%-12.26%+2.82
TrackOppenheimer 81.36 07/29/08 Outperform NS $63.09-9.32%-10.80%+1.48
TrackMorganJos < 20 07/28/08 Outperform NS $62.07-7.83%-11.85%+4.02
TrackJefferies 82.08 07/28/08 Outperform NS $62.07-7.83%-11.85%+4.02
TrackRodmanRen < 20 07/28/08 Outperform NS $62.07-7.83%-11.85%+4.02
TrackDeutscheSec 89.68 06/19/08 Outperform NS $44.41+28.82%-17.10%+45.92
TrackSnow 97.67 06/18/08 Outperform 1Y $44.62+28.22%-17.35%+45.57 Toggle the visibility of 60-Second Pitch and replies
TrackEveillard 93.31 03/31/08 Outperform NS $41.78+36.93%-14.84%+51.77 Toggle the visibility of 60-Second Pitch and replies
TrackSoros 82.58 03/31/08 Outperform NS $41.78+36.93%-15.75%+52.68 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 90.73 12/31/07 Outperform NS $46.44+23.19%-23.57%+46.76 Toggle the visibility of 60-Second Pitch and replies
TrackLehmanBros 85.06 11/15/07 Outperform NS $54.33+5.30%-23.36%+28.66
TrackCreditSuiss 93.62 10/24/07 Outperform NS $57.80-1.02%-25.71%+24.69
TrackBrandes < 20 09/30/07 Outperform NS $56.57+1.13%-26.38%+27.51 Toggle the visibility of 60-Second Pitch and replies
TrackNWQ < 20 09/30/07 Outperform NS $56.57+1.13%-26.38%+27.51 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 98.91 09/30/07 Outperform NS $56.57+1.13%-26.38%+27.51 Toggle the visibility of 60-Second Pitch and replies
TrackHillman 94.73 09/30/07 Outperform NS $56.57+1.13%-26.38%+27.51 Toggle the visibility of 60-Second Pitch and replies
TrackBRogers 97.70 09/30/07 Outperform NS $56.57+1.13%-26.38%+27.51 Toggle the visibility of 60-Second Pitch and replies
TrackRichPzena 38.72 09/30/07 Outperform NS $56.57+1.13%-26.38%+27.51 Toggle the visibility of 60-Second Pitch and replies
TrackMichaelSivy 91.90 03/20/07 Outperform 1Y $55.85+2.44%-19.59%+22.02
TrackBearStearns 84.85 01/04/07 Outperform NS $69.99-18.26%-18.96%+0.70

Results 1 - 25 of 25  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD04 281ms